Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Pechala's Reports
$25.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Merck & Co Inc Reaffirms FY 2012 Revenue Guidance; Narrows FY 2012 EPS Guidance To A Range In Line With Analysts' Estimates


Friday, 26 Oct 2012 07:00am EDT 

Merck & Co Inc announced that for fiscal 2012, it continues to expect revenues to be at or near fiscal 2011 levels on a constant currency basis. At current exchange rates, sales would be affected unfavorably by approximately 1% for the fourth quarter and more than 2% for fiscal 2012. The Company expects non-GAAP EPS to be between $3.78-$3.82 and GAAP EPS range to be $2.08 to $2.24 for fiscal 2012. The fiscal 2012 non-GAAP range excludes acquisition-related costs and costs related to restructuring programs. The Company reported revenue of $48.047 billion in fiscal 2011. According to I/B/E/S Estimates, analysts are expecting the Company to report EPS of $3.81 and revenue of $47.14 billion for fiscal 2012. 

Company Quote

57.09
-0.68 -1.18%
2:50pm EDT